EORTC-GcG/NCIC-CTG Randomised trial comparing primary debulking surgery with neoadjuvant chemotherapy in stage IIIC-IV ovarian, fallopian tube and peritoneal cancer (OVCA)

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Unknown venue

• Publication date

  2008-10-01

• Fields of study

  Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• To compare the optimal cytoreduction rate in advanced epithelial ovarian cancer stage III/IV after 3 versus 6 cycles of neoadjuvant chemotherapy

  2020influential citation
• Clinical and surgical outcomes of 3 cycles versus 6 cycles of neoadjuvant chemotherapy in advanced ovarian carcinoma

  2019cites this paper
• Review of methodological challenges in comparing the effectiveness of neoadjuvant chemotherapy versus primary debulking surgery for advanced ovarian cancer in the United States.

  2018cites this paper
• Association of Diaphragmatic Surgery as Part of Cytoreductive Effort in Advanced Stage Ovarian Cancer.

  2018cites this paper
• Interval Laparoscopic En-Bloc Resection of the Pelvis (L-EnBRP) in patients with stage IIIC-IV ovarian cancer: Description of the technique and surgical outcomes.

  2016cites this paper
• Neoadjuvant chemotherapy and primary debulking surgery utilization for advanced-stage ovarian cancer at a comprehensive cancer center.

  2016cites this paper
• Poly(ADP-ribose) polymerase (PARP) inhibitors for the treatment of ovarian cancer.

  2015cites this paper
• Weekly Paclitaxel and Carboplatin for Patients with Advanced Ovarian Cancer

  2013cites this paper
• Impact of a structured quality management program on surgical outcome in primary advanced ovarian cancer.

  2011cites this paper
• Recent surgical management of ovarian cancer

  2011cites this paper
• Complications de la chirurgie radicale des cancers de l’ovaire de stade avancé

  2011cites this paper
• Ovarialkarzinom: alte Probleme und neue Lösungsansätze

  2011cites this paper
• Advanced cytoreduction as surgical standard of care and hyperthermic intraperitoneal chemotherapy as promising treatment in epithelial ovarian cancer.

  2011cites this paper
• Phase ii /iii study of intraperitoneal chemotherapy after neoadjuvant chemotherapy for ovarian cancer:

  2011cites this paper
• Systemic Therapy for Ovarian Cancer, Current Treatment, Recent Advances, and Unmet Needs

  2011cites this paper
• Comparison of diaphragmatic surgery at primary or interval debulking in advanced ovarian carcinoma: an analysis of 163 patients.

  2011cites this paper
• Bevacizumab and its use in epithelial ovarian cancer.

  2011cites this paper
• The prognostic and predictive value of CA-125 regression during neoadjuvant chemotherapy for advanced ovarian or primary peritoneal carcinoma

  2011cites this paper
• Clinical Approach to Diagnosis and Management of Ovarian, Fallopian Tube, and Peritoneal Carcinoma.

  2011cites this paper
• Ovarian Cancer Management: the role of imaging and diagnostic challenges.

  2011cites this paper
• Current and future directions of clinical trials for ovarian cancer.

  2011cites this paper
• Ginekologia 4.2009 srodek.indd

  2010cites this paper
• Recent studies that influence the chemotherapeutic paradigm in the management of advanced ovarian cancer

  2010cites this paper
• Surgical procedures and morbidities of diaphragmatic surgery in patients undergoing initial or interval debulking surgery for advanced-stage ovarian cancer.

  2010cites this paper
• In vivo intratumor angiogenic treatment effects during taxane-based neoadjuvant chemotherapy of ovarian cancer

  2010cites this paper
• Targeted Therapies in Epithelial Ovarian Cancer

  2010cites this paper
• Review: Practical considerations in ovarian cancer chemotherapy

  2010cites this paper
• The role of neoadjuvant chemotherapy in treating advanced epithelial ovarian cancer

  2010cites this paper
• Can complete tumor resection be predicted in advanced primary epithelial ovarian cancer? A systematic evaluation of 360 consecutive patients.

  2010cites this paper
• Cytoreductive surgery for ovarian cancer

  2010cites this paper
• Imaging ovarian cancer and peritoneal metastases—current and emerging techniques

  2010cites this paper
• Sorafenib in combination with carboplatin and paclitaxel as neoadjuvant chemotherapy in patients with advanced ovarian cancer

  2010cites this paper
• Prediction of 30-day morbidity after primary cytoreductive surgery for advanced stage ovarian cancer.

  2010cites this paper
• The Role of Diaphragmatic Surgery During Interval Debulking After Neoadjuvant Chemotherapy: an Analysis of 74 Patients With Advanced Epithelial Ovarian Cancer

  2010cites this paper
• Intraperitoneal chemotherapy for advanced ovarian and peritoneal cancers in patients following interval debulking surgery or primary cytoreductive surgery: Tom Baker Cancer Centre experience from 2006 to 2009.

  2010cites this paper
• New advances in ovarian cancer.

  2010cites this paper
• The addition of new drugs to standard therapy in the first-line treatment of ovarian cancer.

  2010cites this paper
• Correlation Between Macroscopic and Microscopic Diseases on Splenectomies Performed in the Surgical Management of Ovarian Cancer

  2010cites this paper
• Epithelial ovarian carcinoma: current evidences and future perspectives in the first-line setting

  2010cites this paper
• Serum tetranectin as a preoperative indicator for postoperative complications in Danish ovarian cancer patients.

  2010cites this paper
• Should laparoscopy be included in the work-up of advanced ovarian cancer patients attempting interval debulking surgery?

  2010cites this paper
• Serum tetranectin is a significant prognostic marker in ovarian cancer patients

  2010cites this paper
• First-line treatment of advanced ovarian cancer: current research and perspectives

  2010cites this paper
• Robotic-assisted minimally invasive surgery and ovarian cancer

  2010cites this paper
• Current challenges and future directions in the management of ovarian cancer: Proceedings of the first global workshop on ovarian cancer

  2010cites this paper
• Value of prediction models in determining treatment strategies in patients with advanced stage epithelial ovarian cancer

  2010cites this paper
• The role of neoadjuvant chemotherapy in the management of patients with advanced stage ovarian cancer: survey results from members of the Society of Gynecologic Oncologists.

  2010cites this paper
• The improved visualization and dexterity obtained by robotics increases the proportion of patients that can benefit from the minimally invasive surgical approach.

  2010cites this paper
• DNA-repair pathway inhibitors for the treatment of ovarian cancer.

  2010cites this paper
• Phase II studies demonstrated that docetaxel is active in ovarian cancer in both taxane naive

  2010cites this paper
• Intraoperative hyperthermic intraperitoneal chemotherapy after cytoreductive surgery in ovarian cancer peritoneal carcinomatosis: systematic review of current results

  2009cites this paper
• Chemotherapy for gynecologic cancers.

  2009cites this paper
• Application of a risk scoring system to predict surgical adverse events in the management of epithelial ovarian cancers.

  2009cites this paper
• A statement for extensive primary cytoreductive surgery in advanced ovarian cancer

  2009cites this paper
• Ovarian Cancer Cytoreductive Surgery in the Elderly

  2009cites this paper
• Porównanie chemioterapii neoadiuwantowej z odroczonym zabiegiem cytoredukcyjnym z operacją pierwotną i następową chemioterapią uzupełniającą w leczeniu chorych z rozpoznaniem raka jajnika w III stopniu zaawansowania

  2009cites this paper
• Neoadjuvante Chemotherapie beim Ovarialkarzinom – ein sinnvolles Vorgehen?

  2009cites this paper
• Role of CT scan-based and clinical evaluation in the preoperative prediction of optimal cytoreduction in advanced ovarian cancer: a prospective trial

  2009cites this paper
• The effect of comorbidity on survival in patients with advanced ovarian cancer

  2009cites this paper
• Overview of epithelial ovarian cancer and updates in management strategies

  2009cites this paper
• The place of subtotal/supracervical hysterectomy in current practice

  2009cites this paper
• Prediction of Residual Disease After Primary Cytoreductive Surgery for Advanced-Stage Ovarian Cancer: Accuracy of Clinical Judgment

  2009cites this paper
• Laparoscopic interval surgery for stage 4 primary fallopian tube carcinoma—a case report

  2009cites this paper
• Chemotherapy for Ovarian Cancer in the Older Adult

  2009cites this paper
• Contemporary considerations for neoadjuvant chemotherapy in primary ovarian cancer

  2009cites this paper
• Neoadjuvant chemotherapy followed by interval debulking surgery in patients with serous endometrial cancer with transperitoneal spread (stage IV): a new preferred treatment?

  2009influential citation
• Laparoscopy and ovarian cancer: a paradigm change in the management of ovarian cancer?

  2009cites this paper
• Neoadjuvant chemotherapy with carboplatin and docetaxel in advanced ovarian cancer--a prospective multicenter phase II trial (PRIMOVAR).

  2009cites this paper
• Cediranib, an oral inhibitor of vascular endothelial growth factor receptor kinases, is an active drug in recurrent epithelial ovarian, fallopian tube, and peritoneal cancer.

  2009cites this paper
• Epidermal growth factor receptor blockers for the treatment of ovarian cancer.

  2009cites this paper
• p16INK4a expression in cytology of ascites and response to chemotherapy in advanced ovarian cancer

  2009cites this paper
• Changes in Ki-67 Labeling Indices During Neoadjuvant Chemotherapy for Advanced Ovarian Cancer Are Associated With Survival

  2009cites this paper
• Does Neoadjuvant Chemotherapy Increase Optimal Cytoreduction Rate in Advanced Ovarian Cancer? Meta-Analysis of 21 Studies

  2009cites this paper
• A statement for extensive primary cytoreductive surgery in advanced ovarian cancer

  2008cites this paper
• Treating Older Patients With Ovarian Cancer: Another Perspective

  2008cites this paper
• Major clinical research advances in gynecologic cancer 2008.

  2008cites this paper